Coronavirus response: Generations react differently to COVID-19

Article

generations
Peter McDonnell

According to some pundits in the media, the #BoomerRemover phenomenon is a reflection of the younger generation’s resentment of the problems they attribute to us oldsters: environmental damage, global warming, income inequality, nuclear weapons. 

They assert that it is time for us older people to step aside and let the younger generation take over and provide better solutions.

On the other hand, I have personally observed younger people looking out for their older friends and neighbors by delivering food and other necessities or running errands for them while the epidemic runs its course. 

Related: COVID-19: Life in the time of coronavirus

The demographics of those killed by this pandemic vary distinctly from the 1918-19 so-called “Spanish flu” pandemic that took an estimated 50 million lives and preferentially targeted young individuals (including soldiers, nurses and house officers).

I believe keeping a sense of humor is a good thing, but personally consider it sophomoric behavior to be partying at the beach while using social media cheering on the virus that kills older people. 

But many of us Baby Boomers were not always kind and respectful of our elders when we were young. Isn’t that why they call them college sophomores?

Read more editorials

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.